Whole antibody |
Easiest to formulate. Many clinically approved antibodies available for labeling. Long history of optical- and radio-labeling of antibodies. |
Long blood half-life decreases specificity of signal, especially before blood pool clearance of imaging agent |
Engineered or chemically produced antibody fragments |
These structures retain high binding affinity. Clearance times well suited for imaging. |
Somewhat more complex to formulate compared to whole antibodies |
Targeting peptides |
High throughput screening methods can yield high-specificity agents with rapid clearance times |
Somewhat more complex to formulate compared to whole antibodies |
Small molecules |
High specificity, rapid clearance. Additional targets including intracellular targets, available for imaging |
Fluorochromes and their comparable size to small molecules may affect pharmacokinetics and biodistribution of the resulting labeled ligands |